These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30630693)

  • 21. Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules.
    Bandyopadhyay AS; Asturias EJ; O'Ryan M; Oberste MS; Weldon W; Clemens R; Rüttimann R; Modlin JF; Gast C
    Vaccine; 2017 Dec; 35(52):7283-7291. PubMed ID: 29150209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review.
    Bandyopadhyay AS; Modlin JF; Wenger J; Gast C
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S35-S41. PubMed ID: 30376081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine policy changes and epidemiology of poliomyelitis in the United States.
    Alexander LN; Seward JF; Santibanez TA; Pallansch MA; Kew OM; Prevots DR; Strebel PM; Cono J; Wharton M; Orenstein WA; Sutter RW
    JAMA; 2004 Oct; 292(14):1696-701. PubMed ID: 15479934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)].
    Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Gmyl AP; Yakovenko ML; Korotkova EA; Chernjavskaja OP; Baykova OY; Silenova OV; Krasota AY; Krasnoproshina LI; Mustafina AN; Kozlovskaja LI
    Vopr Virusol; 2016; 61(1):9-15. PubMed ID: 27145594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
    Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
    Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Surveillance of immunization effectiveness and titer of type Ⅰ and type Ⅲ polio vaccine in Beijing before and after the adjustment of immunization strategy in 2012-2018].
    Li J; Zhang ZJZ; Pan JB; Zhang HR; Li RQ; Li MZ; Lu L; Huang F; Wu J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jul; 54(7):779-783. PubMed ID: 32842302
    [No Abstract]   [Full Text] [Related]  

  • 28. Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Prevots DR; Burr RK; Sutter RW; Murphy TV;
    MMWR Recomm Rep; 2000 May; 49(RR-5):1-22; quiz CE1-7. PubMed ID: 15580728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Remarks on the possibility of the introduction of fractionated dose of the inactivated poliomyelitis vaccine in the Latin American Child Immunization Schedule].
    Arbo A; Falleiros-Arlant LH; López EL; Brea Del Castillo J; Martínez de Cuellar C; Moreno G; Rolón R; Cerda J; Eguiazú S;
    Rev Chilena Infectol; 2018 Aug; 35(4):395-402. PubMed ID: 30534926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poliomyelitis - Beijing, China, 2014-2016.
    Zhao D; Ma R; Zhou T; Yang F; Wu J; Sun H; Liu F; Lu L; Li X; Zuo S; Yao W; Yin J
    MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(49):1357-1361. PubMed ID: 29240729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paralytic poliomyelitis associated with the Sabin 3 revertant strain of poliovirus in Bahrain.
    Khalfan SA; Chomel JJ; Mallet L; Fernandes E; Lahlou AI; Lina B; Aymard M
    Ann Trop Paediatr; 2001 Sep; 21(3):223-9. PubMed ID: 11579860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remarks on the possibility of introducing the fractionated dose of the inactivated poliomyelitis vaccine in the Latin American Child Immunization Schedule.
    Arbo A; Falleiros-Arlant LH; López EL; Brea Del Castillo J; Martínez de Cuellar C; Moreno G; Rolón R; Cerda J; Eguiazú S;
    Rev Chilena Infectol; 2019 Feb; 36(1):83-90. PubMed ID: 31095207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Paralytic poliomyelitis in Russian Federation in 1998-2005].
    Ivanova OE; Eremeeva TP; Leshchinskaia EV; Korotkova EA; Iakovenko ML; Cherniavskaia OP; Cherkasova EA; Dragunskaia EM; Dekonenko EP; Martynenko IN; Krasnoproshina LI; Sorokina MP
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (5):37-44. PubMed ID: 18038545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Surveillance of acute flaccid paralysis in Belarus].
    Samoĭlovich EO; Ermolovich MA; Kotova IF; Svirchevskaia EIu; Shimanovich VP; Kozhemiakin AK; Protas II; Fel'dman EV
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (2):24-31. PubMed ID: 17523475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paralytic poliomyelitis--United States, 1980-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(4):79-83. PubMed ID: 9048844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine-associated paralytic poliomyelitis in an infant with perianal abscesses.
    Higashigawa M; Maegawa K; Honma H; Yoshino A; Onozato K; Nashida Y; Fujiwara T; Inoue M
    J Infect Chemother; 2010 Oct; 16(5):356-9. PubMed ID: 20449625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial.
    Sutter RW; John TJ; Jain H; Agarkhedkar S; Ramanan PV; Verma H; Deshpande J; Singh AP; Sreevatsava M; Malankar P; Burton A; Chatterjee A; Jafari H; Aylward RB
    Lancet; 2010 Nov; 376(9753):1682-8. PubMed ID: 20980048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child.
    Hidalgo S; García Erro M; Cisterna D; Freire MC
    Pediatr Infect Dis J; 2003 Jun; 22(6):570-2. PubMed ID: 12828159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
    Duintjer Tebbens RJ; Hampton LM; Thompson KM
    BMC Infect Dis; 2016 Jun; 16():237. PubMed ID: 27246198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poliovirus vaccine options.
    Zimmerman RK; Spann SJ
    Am Fam Physician; 1999 Jan; 59(1):113-8, 125-6. PubMed ID: 9917578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.